Amyloid-beta clearance in Alzheimer's disease

Strong evidence continues to accumulate indicating that amyloid-beta (Aß) is a central part of Alzheimer’s disease (AD) pathogenesis in spite of the negative evidence coming from failed clinical trials. Therefore, mechanisms of clearance of Aß are of great interest in understanding AD pathogenesis a...

Descripció completa

Dades bibliogràfiques

Autors principals:	Robert Marr, Eliezer Masliah
Format:	Online
Idioma:	anglès
Publicat:	Frontiers Media SA 2021
Matèries:	RC321-571 Q1-390 amyloid-beta Signal Transduction Proteases LDL receptors Clearance Alzheimer's disease thema EDItEUR::P Mathematics and Science::PS Biology, life sciences::PSA Life sciences: general issues::PSAN Neurosciences
Accés en línia:	18589
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!